News

Up to 6 cases of the Variant of Concern first identified in Manaus, Brazil (P.1) have been detected in the UK. Public Health England (PHE) has identified 3 of these cases of the Variant of Concern in England.

New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.

Scientists have developed a simplified method to synthesize fluroketones as a replacement for silver catalysts, the precursors for drug design and manufacture.

A research team is tackling the debilitating neurological condition epilepsy with a powerful new seizure predicting mathematical model that will give patients an accurate warning five minutes to one hour before they are likely to experience a seizure, offering enhanced freedom for the patient and cutting the need for medical intervention.

By analysing the genome of tens of thousands of British people, researchers have discovered similarities between the genetic bases of various eating disorders, and those of other psychiatric disorders.

A recent discovery showed that plants heavily rely on a protein complex named the TPLATE complex for vesicle trafficking. In a new study, VIB teams reveal TPLATE's molecular architecture for the very first time.

Genes have been identified that are linked to both higher levels of body fat and protection from some negative health Impacts caused by obesity.

Scientists found that when CD4 T lymphocytes were directly put in close contact with cancer cells, up to a third of them could also kill them.

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes.

Research suggests that vitamin B6 has the potential to lower the odds of patients becoming seriously ill with the coronavirus.